Timothy P Day

Title: Innovations of Timothy P Day

Introduction

Timothy P Day is a notable inventor based in Berkeley, California. He has made significant contributions to the field of biotechnology, particularly in the development of adeno-associated virus (AAV) technologies. With a total of two patents to his name, his work focuses on innovative methods for treating ocular diseases and enhancing gene delivery systems.

Latest Patents

Timothy P Day's latest patents include "Conjugates comprising AAVs and CAS9 polypeptides" and "Compositions and methods of treating ocular diseases." The first patent describes an AAV that features an exterior surface with peptide tags that bond with a binding-partner, allowing for the creation of conjugates that enhance the delivery of bioactive polypeptides. The second patent presents recombinant AAV virions with altered capsid proteins, which improve the ability to cross barriers between intravitreal fluid and retinal cells, thereby increasing infectivity compared to wild-type AAV.

Career Highlights

Throughout his career, Timothy has worked at prestigious institutions such as the University of California and the University of Pittsburgh. His research has significantly advanced the understanding of gene therapy and its applications in treating retinal diseases.

Collaborations

Timothy has collaborated with notable colleagues, including Leah C Byrne and David V Schaffer. These partnerships have contributed to the success of his innovative projects and patents.

Conclusion

Timothy P Day's work exemplifies the intersection of innovation and biotechnology, showcasing his commitment to advancing medical science through his patents and research. His contributions continue to impact the field of gene therapy and ocular treatments.